Compliance Rate
Compliance Rate
42.86%
Compliant submissions
3
Incompliant submissions
4
Total trials
7
My Organizations' Clinical Trials
Showing 525 of 2008 entries
View as:
Phase: N/A
Priority: Normal
Start: 05/31/15
End: 09/30/17
Due: 09/30/18
Phase: N/A
Priority: Normal
Start: 08/31/06
End: 11/30/09
Due: 11/30/10
Phase: N/A
Priority: Normal
Start: 02/27/23
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 04/16/24
End: 04/30/26
Due: 04/30/27
Phase: N/A
Priority: Normal
Start: 01/31/19
End: 12/30/26
Due: 12/30/27
Phase: N/A
Priority: Normal
Start: 08/31/16
End: 03/31/17
Due: 03/31/18
Phase: N/A
Priority: Normal
Start: 11/30/25
End: 12/31/26
Due: 12/31/27
Phase: N/A
Priority: Normal
Start: 02/28/23
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 08/01/17
End: 08/31/25
Due: 08/31/26
Phase: N/A
Priority: Normal
Start: 06/30/05
End: 12/31/10
Due: 12/31/11
Phase: N/A
Priority: Normal
Start: 08/31/03
End: 11/30/14
Due: 11/30/15
Phase: N/A
Priority: Normal
Start: 07/31/10
End: 12/31/14
Due: 12/31/15
Phase: N/A
Priority: Normal
Start: 06/01/25
End: 05/31/26
Due: 05/31/27
Passive VS Active VR on HPT Using the Thermal Sensory Analyzer With a Peltier-Based Contact Thermode
Phase: N/A
Priority: Normal
Start: 08/04/23
End: 01/03/24
Due: 01/03/25
Phase: N/A
Priority: Normal
Start: 10/05/18
End: 04/05/20
Due: 04/05/21
Phase: N/A
Priority: Normal
Start: 12/31/24
End: 12/31/26
Due: 12/31/27
Phase: N/A
Priority: Normal
Start: 05/01/25
End: 01/31/27
Due: 01/31/28
Contrast-Enhanced Digital Mammography(CEDM) vs Contrast-Enhanced Breast MRI(CE-MRI) in Breast Cancer
Phase: N/A
Priority: Normal
Start: 04/30/15
End: 08/18/17
Due: 08/18/18
Phase: N/A
Priority: Normal
Start: 09/30/06
End: 08/31/11
Due: 08/31/12
Phase: N/A
Priority: Normal
Start: 07/31/09
End: 12/31/09
Due: 12/31/10
Phase: N/A
Priority: Normal
Start: 06/01/21
End: 05/31/25
Due: 05/31/26
Phase: N/A
Priority: Normal
Start: 04/30/04
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 09/30/06
End: 07/31/11
Due: 07/31/12
Phase: N/A
Priority: Normal
Start: 09/30/25
End: 11/30/26
Due: 11/30/27
Phase: N/A
Priority: Normal
Start: 06/30/16
End: 11/17/17
Due: 11/17/18